# EDGAR Filing Document

**Accession Number:** 0002048576
**File Stem:** 0002048576-26-000002
**Filing Date:** 2026-3
**Character Count:** 3022
**Document Hash:** 54d165f53023df8debf467bb6e39b50a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002048576-26-000002.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0002048576-26-000002

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Berkshire Biomedical Corp
- **CENTRAL INDEX KEY:** 0002048576

**ORGANIZATION NAME:**
- **EIN:** 873054745
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-35585
- **FILM NUMBER:** 26819351

**BUSINESS ADDRESS:**
- **STREET 1:** 5950 BERKSHIRE LN, STE 375
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225
- **BUSINESS PHONE:** 214-389-1748

**MAIL ADDRESS:**
- **STREET 1:** 5950 BERKSHIRE LN., SUITE 375
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225

### Attached PDF Documents

**Attachment 1:** `form_car.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Berkshire Biomedical Corporation

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 07-19-2016

**Physical Address:** 5950 Berkshire Ln., Suite 375, Dallas, TX, 75225

**Issuer Website:** https://www.berkshirebiomedical.com/

**Is there a Co-Issuer?:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 3

**Total Assets (Most Recent Fiscal Year):** $212,889.00

**Total Assets (Prior Fiscal Year):** $173,383.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $132,063.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $159,350.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $0.00

**Short-Term Debt (Prior Fiscal Year):** $0.00

**Long-Term Debt (Most Recent Fiscal Year):** $1,000,000.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $197,454.00

**Revenues/Sales (Prior Fiscal Year):** $221,860.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $59,066.00

**Net Income (Prior Fiscal Year):** $-4,258,282.00

### Signatures

**Issuer:** Berkshire Biomedical Corporation

**Signature:** John Timberlake

**Title:** President & CEO

---

**Signature:** John Timberlake

**Title:** President & CEO

**Date:** 03-30-2026

---

**Signature:** John Timberlake

**Title:** President & CEO

**Date:** 03-30-2026

---

**Signature:** Thomas M Rouse

**Title:** Board Chair

**Date:** 03-30-2026

---

**Signature:** Susan Owen

**Title:** Director

**Date:** 03-30-2026